logo
Canberra pilot program to allow select GPs to diagnose ADHD and prescribe medication

Canberra pilot program to allow select GPs to diagnose ADHD and prescribe medication

For Deranie Jackson, finding a specialist in Canberra to assess her child for attention deficit hyperactivity disorder (ADHD) was like finding a needle in a haystack.
Instead, on a friend's recommendation, Ms Jackson made an appointment for Phoebe with a psychologist in Orange, 300 kilometres from home.
Within weeks, Phoebe had their diagnosis — a moment the Year 12 student, who uses they/them pronouns, described as empowering.
"For me, the main thing it impacted was my school life," they said.
"It made me realise that I wasn't really bad at these subjects, I just process slower and need a slower environment.
The diagnosis came in late 2023 but by November last year, it became clear that Phoebe could benefit from medication to treat their ADHD.
"Phoebe was really struggling with school, despite working so hard," Ms Jackson said.
"There were days when Phoebe just couldn't think properly, and I just knew they couldn't do their HSC under these conditions."
Psychologists are unable to prescribe medication for ADHD so the hunt for a specialist — namely, a psychiatrist — began.
Phoebe's general practitioner (GP), who specialises in ADHD, gave them and Ms Jackson a list of eight specialists in the ACT to contact.
"I have spent eight months making phone calls, trying to get in, sending emails — and they've either not got back or their books are closed or they only do under-18s," Ms Jackson said.
"Even though we've got a diagnosis and we've already paid more than $1,000 for that, it was still such a struggle to find a psychiatrist.
No one on the list could see Phoebe ahead of the HSC in October, so Ms Jackson called the psychologist in Orange who made the diagnosis and was recommended a psychiatrist in Albury, more than 300km away.
They have an appointment later this month.
Phoebe said it had felt like they were in a race against time to access medication before the HSC started.
"It's just taken so long and such a toll — I see Mum making phone calls all the time and I'm so grateful that she's doing all that for me," they said.
"I really want the medication in time so I don't do really badly on the HSC because I really dislike not doing my best, which is what can happen if I'm not processing properly."
As for Ms Jackson, the single mother doesn't understand why such a common condition is so hard and expensive to diagnose and treat.
"This is life and death stuff for our children and it's not that the professionals aren't amazing, they just don't have capacity. There aren't enough of them.
"I don't know why it's so hard."
Soon, it won't be.
The ACT's chief psychiatrist Dr Anthony Cidoni made a commitment in May last year to improving access to ADHD diagnosis and prescribing within 12 months.
A little beyond that deadline, he's revealed plans for a pilot program that will see GPs given more authority to diagnose the condition and additional powers to prescribe ADHD medication — a task currently only done by paediatricians, neurologists and psychiatrists, who often have lengthy wait lists and charge high fees.
Queensland has had a similar system in place since 2017 for patients aged between four and 18, while New South Wales, Western Australia and South Australia have also committed to rolling out a GP-led ADHD program for young people next year.
"So, we're really mindful that we need to do something to address the issues that are out there."
In late 2023 a Senate inquiry into ADHD recommended the development of uniform prescribing rules be expedited to ensure consistency between all jurisdictions.
But Dr Cidoni said it had become evident that achieving that recommendation could take years, and ACT Health decided it couldn't afford to wait.
"We don't want to wait for that because we think the need is there now," Dr Cidoni said.
The pilot program is slated to start as early as December but no later than January next year, following stakeholder consultation.
Canberra GPs already have some prescribing arrangements, which allow them to prescribe ADHD medication for adolescents for two years and adults for three years, as recommended by a specialist.
"What we have planned is two streams — one stream will be for GPs to be able to do the actual diagnosis and prescribing, and the other stream will be to do the prescribing but on a much broader level than we have now.
"So, I think we're looking at quite a significant change."
General practitioners will have to apply to take part in the pilot program and, if approved, will need to complete comprehensive training before taking on patients.
There will be clinical supervision by a specialist and a requirement for a GP to refer complex patients to either a paediatrician, psychiatrist or neurologist.
"We've already scoped the level of interest in our GPs in the ACT so we're thinking there would be around 70 to 100 that might be interested in participating in a program like this," Dr Cidoni said.
"A smaller proportion in the diagnosing and treatment arm, and then a larger proportion in the prescribing arm.
"And if we get the parameters right, in terms of the appropriate education, psychiatrist oversight and access to ongoing support, I believe we can do it safely.
When paediatrician Dr Kim Bland was told GPs would soon take on more of the ADHD workload, she breathed a sigh of relief.
And Dr Bland suspects specialists across Canberra will do the same when they hear the news.
"Even with my books closed and that being well-known, we are still getting daily inquiries from families not just looking for care like they would for other medical conditions, but being in crisis.
"Not just asking for medical care, but asking for help and rescuing because they're really in a desperate and dire situation, and that's the difference with these children."
Dr Bland said every aspect of life is impacted for a child living with undiagnosed ADHD, especially their education and self-esteem, plus the pressure on parents can lead to family breakdown.
She said turning those families away is one of the most difficult parts of her job.
"For parents, it's one thing to not know what they can do for their children but it's another to know it's right there, help is available, a diagnosis is available and all the support that comes with it, but they can't access it," Dr Band said.
And for her, to know there will soon be a team of competent GPs to refer those families to feels like a weight being lifted.
Dr Kerrie Aust, the ACT president for the Australian Medical Association, said it made perfect sense for general practitioners to play a more significant role in the ADHD space.
She is hopeful she will get approval to be among the group of GPs able to diagnose ADHD and prescribe medication for the condition.
"We are seeing an increase in young people and adults coming in to have discussions about whether they might have ADHD and it's really important they access care in a timely manner," Dr Aust said.
"While psychiatrists and paediatricians have really been trying to step up into that space, I think this is a good example where GPs can work to the full of their breadth of scope and get involved in the diagnosis and management, especially where those cases are relatively straightforward and we've got proven treatments to work."
Dr Aust said she was confident the take-up by general practitioners would be strong enough to have an impact on patient care.
"Every little bit counts — if one doctor can see two or three new patients a week then that's a huge change to the backlog," Dr Aust said.
"It also creates space for the paediatricians and psychiatrists to focus their attention on some of the more complex diagnostic cases, or where we're having trouble managing the medications."
But she warned potential patients not to expect a diagnosis within a standard quarter-hour consultation.
"It's not going to be a case of booking the 15-minute appointment and coming in and walking out with a diagnosis — it will still take time and patience, and we may need to try a few things before we get it right.
"But I do think being able to access regular care with your GP is a really positive step."
There will be an age limit for patients being seen as part of the pilot, with Dr Cidoni still to decide whether 18 or 26 is the most appropriate option.
Dr Bland said she would urge him to extend the age to 26.
"Usually by the time they're an adult, they're on a very stable dose, they've got a very good support around them, they know when they need to speak to their therapist, they know when they need to adjust their dose.
"And if anything, it's slightly more simple diagnosing past that age so that would be a group I think would benefit greatly from seeing their GP."
Dr Aust agreed, adding she had seen a growing gap in care for patients aged between 16 and 24.
"Often young people who have been diagnosed when they were in primary school, they may have been lost to follow-up for a long period of time and we don't have access to their previous diagnostic records," she said.
"And in those cases, it's both challenging and expensive to have those assessments.
"We really find that they run into trouble as they get into the workplace or they're attending university and that's a group that I would really love to see supported."
Both doctors agreed that it should be a question of complexity, not age, but acknowledged the pilot program had to start with some parameters in place.
When Ms Jackson considers how Phoebe's experience could have been different had their diagnosis come from a general practitioner, she is brought to tears.
"If we'd been able to go to a GP and they could have done tests the moment the anxiety and depression started, it would have been a totally different journey," Ms Jackson said.
"School would have been a completely different experience for Phoebe, I would have parented differently — so much would have been different.
"And it would have been so much more affordable. The cost is a really big impact — it is costing thousands of dollars out-of-pocket for these specialist appointments.
"It's obviously too late for us, but maybe there's a little undiagnosed girl in Year 7 who can be picked up by her GP and find life a much easier journey as a result."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Concerning daycare images show children with their mouths taped shut in yoga exercise
Concerning daycare images show children with their mouths taped shut in yoga exercise

News.com.au

time5 hours ago

  • News.com.au

Concerning daycare images show children with their mouths taped shut in yoga exercise

A Sydney daycare centre has received a warning from the NSW Department of Education after concerning images emerged of children with their mouths covered with tape. The toddlers at Heritage House in Wahroonga, on Sydney's north shore, were participating in a breathing exercise as part of a yoga session last year. No injuries were reported from the exercise which was meant to be relaxing, but the Department launched an investigation into the matter after concerns were raised by a parent. 'While no children were harmed in this incident, it was an inappropriate activity that should not have taken place in an early learning centre,' a spokesperson from the NSW Early Childhood Education and Care Regulatory Authority told 'A thorough investigation was immediately conducted and a compliance action issued to the approved provider, which remains on their record.'  An external visitor was not running the yoga session, and the centre provided evidence to the Department that the mouth taping exercise has since been discontinued.  In a statement, Heritage House told the Sydney Morning Herald: 'It was a well-intentioned activity led by one of our educators, a yoga instructor.' 'We accept that the Department issued a warning and as a result we took steps to ensure that the activity was not repeated.' Photos of the activity were shared on the centre's parents app alongside a caption where an educator described the activity as 'unique'. 'The children gathered for a unique lesson combining breathwork, gentle yoga, and the tape-mouth technique. Guided to focus on nasal breathing, they playfully mimicked animals in yoga poses, learning to breathe deeply and calmly through their noses, fostering early mindfulness,' they wrote, according to SMH. A number of parents whose children attend the daycare threw their support behind the centre and its educators on Tuesday. One parent told 7News: 'They've always been very careful about the kids, their growth, their education, everything.' Another said: 'People are friendly, they seem engaged, kids are happy here.' Mouth taping, specifically for adults prone to mouth breathing while sleeping, has become a recent trend on TikTok but concerns have been raised about the dangers of restricting airflow.

EMVision to start two key studies
EMVision to start two key studies

The Australian

time7 hours ago

  • The Australian

EMVision to start two key studies

EMVision receives ethics approval for two studies that will advance prototype First Responder toward commercial production Studies designed to demonstrate First Responder brain scanner can fit into emergency workflows and collect valuable data in pre-hospital setting EMVision non-dilutive milestone payment received under Australian Stroke Alliance Project Agreement Special Report: EMVision Medical Devices has passed a major milestone with ethics approval granted for two key studies to advance its First Responder prototype portable device to detect stroke and traumatic brain injury (TBI). EMVision Medical Devices (ASX:EMV) said the Royal Flying Doctor Service (RFDS) pre-hospital aeromedical study and Melbourne Mobile Stroke Unit (MSU) study would advance its First Responder brain scanner toward commercial production. The studies are designed to demonstrate that the First Responder device can fit seamlessly into emergency workflows and collect valuable data in the pre-hospital setting. First Responder is EMVision's second device and designed to address significant unmet needs in stroke and TBI care by enabling earlier triage, transfer or treatment decisions at the scene. The device is being advanced in parallel with its emu bedside scanner to rapidly diagnose stroke at the point-of-care, which is currently in a pivotal trial to support US Food and Drug (FDA) de novo (new device) clearance. RFDS pre-hospital aeromedical study Ethics approval has been granted for a feasibility, usability and workflow implementation aeromedical study. The study is a collaboration of RFDS, South Australia Ambulance Service's emergency retrieval service MedStar, South Australia Health's Rural Support Services, the Royal Adelaide Hospital and the Australian Stroke Alliance. The study will evaluate the First Responder device's usability, reliability, functionality, workflow metrics and other tests as necessary to meet user and international regulatory requirements. EMVision said the study was on track to start recruitment this quarter, with study results expected to be reported next quarter. Melbourne Mobile Stroke Unit (MSU) Ethics approval has also been granted for a First Responder study during acute suspected stroke cases attended by the Melbourne Mobile Stroke Unit (MSU). EMVision said the study provided a unique opportunity to collaborate with the only MSUs in Australia and one of a few MSUs globally who participate in clinical research. The study aims to evaluate the use of First Responder during pre-hospital emergency response to acute suspected stroke patients, while gathering contemporaneous ground-truth MSU CT-scan data. This study is forecast to start later this quarter. Milestone payment of $400,000 from ASA In a further boost EMVision has reached a key development milestone under its project agreement with the Australian Stroke Alliance (ASA), supported by the Federal Government's Medical Research Future Fund (MRFF). The company has received a $400,000 non-dilutive payment for completing the Telemedicine and Road/Air Integration milestone, an achievement that advances its First Responder portable brain scanner program. EMVision's CEO Scott Kirkland said the company was delighted to report successful achievement of the important milestone, which brings together the power of its point-of-care neurodiagnostic capabilities with the reach of telehealth. 'This combination has the potential to transform patient workflows and outcomes, particularly in the pre-hospital setting,' he said. 'In the coming months, EMVision will be conducting several studies to progress development of its First Responder device, which will be integral to expediating its commercialisation via the FDA 510(k) regulatory pathway. 'We look forward to communicating the results of these studies to the market in due course.' First responder pathway to market entry Source:EMVision This article was developed in collaboration with EMVIsion, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.

Albanese government praises ‘critical' program in teen vape fight
Albanese government praises ‘critical' program in teen vape fight

News.com.au

time7 hours ago

  • News.com.au

Albanese government praises ‘critical' program in teen vape fight

The Albanese government is celebrating after a key study found an anti-vaping program is helping curb the spike in fuming teens. A randomised controlled trial involving some 5000 students from 40 schools found participants were 65 per cent less likely to vape after 12 months when compared to students who did not take part in the program. The findings were published on Tuesday in the world leading health journal, The Lancet. Health Minister Mark Butler praised the results, calling the program 'a critical part of our vaping strategy'. 'Vaping rates exploded, especially in the last five years, literally exploded year on year,' Mr Butler told reporters at Parliament House, flanked by students. 'This was sold to countries around the world as a therapeutic good that would allow hardened smokers, usually in middle age, to kick the habit if other attempts to kick smoking had not worked. 'But what we found relatively quickly was this was quite a different strategy by big tobacco. 'It was a strategy to recruit a new generation to nicotine addiction.' He said he was 'delighted we have been able to fund' the program, run by the Our Futures Institute. Under the program, students learn about the harms of vaping through visual stories and game-like activities, such as quizzes. In 2019, 9.6 per cent of teens aged 14-17 were estimated to have used vapes, according to official data. It nearly tripled to 28 per cent by 2023. Earlier this year, the Albanese government said numbers the numbers were falling after a series of measures aimed at curbing the uptake among young Australians. Among the measures were banning single-use vapes. According data put out in January, vaping rates for Australian 15 and had fallen more than a third since 2023. The data also showed the number of 'never-vapers' among 14-17-year-olds had reached a record high of 85 per cent.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store